Software Alternatives & Startups
Register | Login

DossiMed.ai VS GitHub Surf

Compare DossiMed.ai VS GitHub Surf and see what are their differences

DossiMed.ai

Multilingual medication-adherence & PHR platform for insurers, telcos & pharma — AI prescription OCR, push/WhatsApp/AI-voice reminders, no-login doctor viewer. GDPR-by-design, EU-hosted, FR/AR/EN/NL. White-label, license, or full IP transfer.

Rating
0 reviews
Pricing
Freemium Free trial $3.9 / Monthly
Promote on VibeVoted
Alternatives Is it good?
GitHub Surf

Open repositories in a VSCode environment in your browser

No screenshot yet
Rating
0 reviews
Pricing
Open source
Promote on VibeVoted
Alternatives Is it good?
boldrouter
A unified, OpenAI-compatible gateway to every major LLM provider. One endpoint, one key, one bill - with automatic routing and failover. sponsored
Note: These products don't have any matching categories. If you think this is a mistake, please edit the details of one of the products and suggest appropriate categories.

Which is more popular?

Healthcare popularity
100% vs 0%
alternatives listed
7 vs 1

Base details

Website, pricing, platforms and company facts side by side.

DossiMed.ai
GitHub Surf
Website dossimed.ai github.surf
Pricing
Freemium Free trial $3.9 / Monthly Official pricing
Open source
Platforms
Android iOS
—
Company Startup from Tunisia · 1 - 9 employees · 2026 —
Listed in
Telehealth Healthcare Health And Medical Telemedicine Medical Practice Management AI +3
Developer Tools Productivity Note Note Taking +1

About DossiMed.ai and GitHub Surf

In their own words, as submitted to SaaSHub.

DossiMed.ai
GitHub Surf

DossiMed is a production-grade medication-adherence and personal-health-record (PHR) platform, built for European compliance and natively localized for French, Arabic, English, and Dutch markets. It is the only platform that combines AI prescription OCR, Arabic RTL-first design, multichannel...

Read more about DossiMed.ai

No description of GitHub Surf yet.

Features and specs

What each product offers, as listed by its team.

DossiMed.ai 9 features
GitHub Surf 4 features
  • Prescription OCR
    AI-assisted digitization of paper prescriptions and lab reports
  • Medication adherence
    Multichannel reminders: push, WhatsApp, multilingual voice calls
  • Physician viewer
    Read-only doctor access with QR share and audit logs
  • White-label deployment
    Partner branding, locale, sovereign cloud rollout in 6–10 weeks
  • GDPR-by-design
    Articles 13, 9, 27; EU hosting in Switzerland (eu-central-2)
  • Multilingual localization
    Native French, Arabic, English, and Dutch for MENA and EU markets
  • Personal health record
    Secure PHR for prescriptions, labs, and medical documents
  • Family profiles
    Dependent and cohort profiles for insurers and caregivers.
  • Technology licensing
    Exclusive license or full IP transfer by territory or therapeutic area
  • User-Friendly Interface
    GitHub Surf provides an intuitive and easy-to-navigate interface that makes it accessible for both beginners and experienced users.
  • Integration with GitHub
    The tool seamlessly integrates with GitHub, allowing users to easily access repositories and track changes efficiently.
  • Real-Time Collaboration
    It supports real-time collaboration features, enabling multiple users to work on the same project simultaneously and see each other's edits instantly.
  • Visual Representation
    Provides a visual representation of project histories and branches, which helps in understanding the development process better.

Possible disadvantages

  • Limited Offline Capabilities
    GitHub Surf requires an internet connection for most functionalities, which limits its usability in offline scenarios.
  • Learning Curve
    Users new to GitHub or similar platforms might experience a learning curve when first using GitHub Surf, owing to its various features and tools.
  • Performance Issues
    Some users may experience performance lags or slower response times when working with large repositories.
  • Privacy Concerns
    As with any online tool, there might be concerns related to data privacy and security, especially when dealing with sensitive project information.

Analysis

An editorial look at what each product does well and who it suits.

DossiMed.ai
GitHub Surf

Overall verdict

  • I don't have verified, specific information about DossiMed.ai to make a reliable assessment of its quality, features, or performance. I cannot confirm whether this is a legitimate, well-reviewed medical/health-related AI service or provide details about its actual capabilities.

Why this product is good

  • Insufficient verified data available about this specific platform
  • Cannot confirm the company's track record, user reviews, or clinical validation if it's health-related
  • No access to independent testing or user feedback on this product
  • Unable to verify claims the platform may make about its AI capabilities or accuracy

Recommended for

  • Users should independently research DossiMed.ai through official sources, user reviews, and industry publications
  • Verify any medical or health-related claims with qualified healthcare professionals
  • Check for regulatory compliance if the tool is used in clinical or diagnostic contexts
  • Look for third-party validation studies if precision or medical accuracy is claimed
  • Consult recent user reviews and testimonials from verified sources before adoption

Overall verdict

  • GitHub Surf appears to be a niche tool designed to enhance the experience of browsing and exploring GitHub repositories, offering a more visual or streamlined interface than GitHub's native UI. It seems useful for developers who want a faster or more intuitive way to navigate codebases, though as a smaller or newer service, it may lack the robustness, feature completeness, or long-term support of GitHub's official tools.

Why this product is good

  • Provides an alternative, potentially more visual or user-friendly way to browse GitHub repositories
  • May offer quicker navigation or discovery features compared to GitHub's default interface
  • Useful for developers who want to explore codebases without cloning them locally
  • Likely lightweight and focused on a specific browsing use case

Recommended for

  • Developers who frequently browse open-source repositories and want a different visual experience
  • Users looking for quick repository exploration without needing full GitHub account features
  • Casual coders or students exploring codebases for learning purposes
  • Those seeking alternative UI/UX for GitHub navigation as a supplementary tool

Videos

Walkthroughs and reviews on video.

DossiMed.ai 1 video + Add
GitHub Surf 0 videos + Add

DossiMed demo

No GitHub Surf videos yet. You could help us improve this page by suggesting one.

Category popularity

How often each product is chosen within a category, 0–100% relative to the other.

Score bands 0–20 21–40 41–50 51–60 61–100
DossiMed.ai
GitHub Surf
100% 100%
Healthcare
0% 0%
0% 0%
Productivity
100% 100%
100% 100%
Medical Practice Management
0% 0%
0% 0%
Note Taking
100% 100%

Questions & Answers

As answered by people managing DossiMed.ai and GitHub Surf.

Who are some of the biggest customers of your product?

DossiMed.ai's answer

DossiMed is in its market-entry and partnership phase and does not yet publicly disclose named customers. The consumer app is live on Google Play for patients and families, and these are the enterprise segments DossiMed engages for white-label, licensing, and IP-transfer deployments:

  • Health insurers (member medication-adherence and chronic-care programs)
  • Telecom operators (health value-added services for subscribers)
  • Pharmaceutical groups (patient-support and adherence programs)
  • Public-health bodies and NGOs across MENA and Africa

Partnership inquiries: https://dossimed.ai/en/partnerships

Which are the primary technologies used for building your product?

DossiMed.ai's answer

  • Flutter — offline-first cross-platform mobile app (Android and iOS)
  • Supabase / PostgreSQL — hosted in Switzerland (eu-central-2, Zürich) for GDPR adequacy
  • Azure Document Intelligence + GPT-4o — OCR and structuring of prescriptions, lab results, and imaging reports
  • Serverless edge functions — the AI extraction pipeline, portable across AI providers
  • WhatsApp Business API — medication reminder escalation
  • AI voice-call integration — multilingual (French, Arabic, English) voice reminders
  • Web doctor viewer (viewer.dossimed.ai) — read-only access via QR code or secure link, no app or account required

What makes your product unique?

DossiMed.ai's answer

DossiMed is the only personal health record that bundles AI prescription OCR, a truly multilingual experience (French, Arabic, English, Dutch — with Arabic RTL-first design), a multichannel medication-adherence escalation stack (push → WhatsApp → AI voice call), and a no-login doctor share link in a single app.

It turns paper prescriptions and lab reports into structured, queryable records, auto-generates a visual dosing calendar with real dosage-form icons (pill, half-pill, syrup, drops, inhaler, patch), and lets a whole family be managed in one secure vault. Doctors open a time-limited, read-only view by QR code or secure link — no account, no install. GDPR-by-design, hosted in Switzerland (Supabase eu-central-2).

Why should a person choose your product over its competitors?

DossiMed.ai's answer

Most alternatives solve only one slice of the problem. Medication apps like Medisafe and MyTherapy are US/EU-centric, manual, and have no Arabic, no AI OCR, and no document vault. National records (Mon Espace Santé, NHS App) are country-bound, with no AI structuring and no escalation reminders. Booking platforms (Doctolib, DabaDoc, Vezeeta) handle appointments, not a patient-owned record.

DossiMed is the only app that combines AI prescription structuring, Arabic RTL, WhatsApp + AI-voice reminder escalation, and a no-login doctor share link in one place — purpose-built for the people across Africa, MENA, and their diasporas who carry paper prescriptions and rely on WhatsApp. It also runs offline-first on low-cost Android devices. Free core tier; Premium from $2.99/month.

How would you describe the primary audience of your product?

DossiMed.ai's answer

DossiMed serves two audiences.

Consumers: patients and families managing chronic conditions, elderly relatives, and children's treatments — across Francophone Europe, the Netherlands, Tunisia, the Maghreb, the broader MENA region, and African and diaspora communities. It is built especially for multilingual households that need French, Arabic, English, or Dutch in a single family vault, and for caregivers managing a relative's medication from afar.

Partners (B2B): health insurers, telecom operators, and pharmaceutical groups that want a production-grade, GDPR-by-design chronic-care platform to deploy white-label, license by territory or therapeutic area, or acquire as full IP.

What's the story behind your product?

DossiMed.ai's answer

DossiMed was built by REC SUARL, an export-oriented Tunisian software company, and founded by Yasmine Boudhina — an INSAT engineer with 13+ years in infrastructure and DevOps, a Microsoft Certified Trainer, and a top-3 alum of Founder Institute Middle East.

The idea came from a problem most Western health-tech overlooks: across Africa, the Arab world, and their diasporas, the majority of prescriptions are still handwritten or printed on paper, there is no national patient record, and families coordinate care over WhatsApp. People lose prescriptions, miss doses, and arrive at appointments with no history.

DossiMed was created to give those patients a record that is always with them — multilingual (French, Arabic, English, Dutch), AI-structured, and shareable with any doctor in seconds. It is production-grade, GDPR-by-design, and hosted in Switzerland.

User comments

Share your experience with using DossiMed.ai and GitHub Surf. For example, how are they different and which one is better?

Log in or Post with

Alternatives to DossiMed.ai and GitHub Surf

When comparing DossiMed.ai and GitHub Surf, you can also consider the following products.

Loading...